Phase 1 Advanced Solid Tumors Cancer Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.

Advanced Solid Tumors CancerMSI-H Cancer

Nimbus Wadjet, Inc.134 enrolled22 locationsNCT06898450

Recruiting

Phase 1

ORB-021 In Patients With Advanced Solid Tumors

Advanced Solid Tumors Cancer

Orionis Biosciences Inc36 enrolled2 locationsNCT06607939

Recruiting

Phase 1Phase 2

A Study of GFH375 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors Harboring KRAS G12D Mutation

Advanced Solid Tumors CancerPDACCRC (Colorectal Cancer)

Genfleet Therapeutics (Shanghai) Inc.126 enrolled4 locationsNCT07259590